1. Clinical Effectiveness of Lifestyle Management Programs: Importance of the Class Effect Paradox

   • Neil F. Gordon

   Invited Commentary 24 August 2013 Pages: 675 - 680

2. Inflammation and Atherosclerosis: Disease Modulating Therapies

   • Mahesh J. Patel
   • Michael A. Blazing

   Prevention (L Sperling, Section Editor) 25 August 2013 Pages: 681 - 695

   

3. Recent Developments in the Treatment of Familial Hypercholesterolemia: A Review of Several New Drug Classes

   • Michael J. Wilkinson
   • Michael H. Davidson

   Prevention (L Sperling, Section Editor) 13 November 2013 Pages: 696 - 705

   

4. Standard and Novel Treatment Options for Metabolic Syndrome and Diabetes Mellitus

   • Elliott M. Groves
   • Katherine Yu
   • Shaista Malik

   Prevention (L Sperling, Section Editor) 15 November 2013 Pages: 706 - 721

5. Is There a Role for Menopausal Hormone Therapy (MHT) for Cardiovascular Disease Prevention in Select Postmenopausal Women?

   • Alexis Cutchins
   • Nanette K. Wenger

   Prevention (L Sperling, Section Editor) 17 July 2013 Pages: 722 - 734

6. Vegetarian Diets in Cardiovascular Prevention

   • M. Dominique Ashen

   Prevention (L Sperling, Section Editor) 09 August 2013 Pages: 735 - 745

7. Use of Ambulatory Blood Pressure Monitoring to Guide Hypertensive Therapy

   • Amita Singh
   • Eugenia Gianos
   • Howard Weintraub

   Prevention (L Sperling, Section Editor) 10 July 2013 Pages: 746 - 760